The experiment was meant to have occurred in Oct 2018, but the Soyuz MS-ten spacecraft carrying cosmonaut Alexey Ovchinin and the bioprinter experienced abooster failure, forcing the crew to abort. Both Ovchinin and astronaut Nick Hague escaped securely, but the printer was noticeably weakened. A backup was promptly prepared and the new crew, such as Kononenko, had been properly trained on its use. They launched to the ISS once more onDecember third, and the bioprinting experiments commenced soon afterwards.
Roscosmos, Russia’s equal to NASA, hardly ever collaborates with personal companies, but will start out to do so significantly more in the potential, it mentioned. NASA is also setting up bioprinting experiments in the first half of 2019, but Russia receives bragging legal rights for carrying out it to start with.
With the initial living tissue made, the future move is to see how the microgravity in the ISS influenced its growth. The house-printed biological product has already been returned to Earth aboard the Soyuz MS-09 on December twentieth (alongside with NASA astronaut Serena Auñón-Chancellor, German astronaut Alexander Gerst of the European Area Company and Russian cosmonaut Sergey Prokopyev). Roscosmos stated outcomes of the take a look at will be revealed sometime in January, 2019.